225 related articles for article (PubMed ID: 4988303)
1. [The feasibility of using the fluorescent antibody technic in immunologic studies of tuberculosis].
Gogebashvili NV; Averbakh MM
Biull Eksp Biol Med; 1967 Sep; 64(9):71-4. PubMed ID: 4988303
[No Abstract] [Full Text] [Related]
2. [Studies on the specificity and antigenic composition of fractions from Mycobacterium tuberculosis, bovine type and Mycobacterium fortuitum. 3. Hemagglutination, hemolysis and complement fixation reactions].
Micke H
Z Immunitatsforsch Allerg Klin Immunol; 1966 Aug; 131(2):134-69. PubMed ID: 4231175
[No Abstract] [Full Text] [Related]
3. [Studies on the specificity and antigenic composition of fractions of Mycobacterium tuberculosis, bovine type, and Mycobacterium fortuitum. 2. Antigen-antibody reactions].
Micke H
Z Immunitatsforsch Allerg Klin Immunol; 1966 Jul; 131(1):1-20. PubMed ID: 4229105
[No Abstract] [Full Text] [Related]
4. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
[TBL] [Abstract][Full Text] [Related]
5. [The lung in tuberculosis as an immunocompetent organ].
Averbakh MM; Gogebashvili NV; Litvinov VI
Biull Eksp Biol Med; 1970 Aug; 70(8):70-3. PubMed ID: 4923923
[No Abstract] [Full Text] [Related]
6. [Chemical and immunologic studies of 2 antigen active preparations with polysaccharide characteristics obtained from Mycobacterium tuberculosis and Mycobacterium bovis (BCG)].
Klose F; Weyhers M
Z Immunitatsforsch Allerg Klin Immunol; 1967 Jun; 133(1):7-10. PubMed ID: 4232429
[No Abstract] [Full Text] [Related]
7. Experimental immunity against tuberculosis evoked by peptidoglycolipids of the wax D type.
Pokorný J; Sulová J; Zák F
Z Immunitatsforsch Allerg Klin Immunol; 1968 Aug; 136(2):118-28. PubMed ID: 4234690
[No Abstract] [Full Text] [Related]
8. [Specific antigens in organs and tissues in experimental BCG vaccination].
Litvinov VI
Probl Tuberk; 1968; 46(3):51-6. PubMed ID: 4878381
[No Abstract] [Full Text] [Related]
9. [Attempts at isolation and characterization of immunogenically active fractions of Mycobacterium tuberculosis and Mycobacterium bovis (BCG). 3. Immunochemical properties of the fractions].
Klose F; Schallehn G
Z Immunitatsforsch Allerg Klin Immunol; 1966 Sep; 131(3):201-18. PubMed ID: 4231179
[No Abstract] [Full Text] [Related]
10. [An immunofluorescent and serologic study of early reactions to the administration of BCG and H37Rv mycobacteria].
Averbakh MM; Gogebashvili NV; Litvinov VI; Romanova RIu
Biull Eksp Biol Med; 1968 Aug; 66(8):33-6. PubMed ID: 4921083
[No Abstract] [Full Text] [Related]
11. [In vitro leukocyte reaction to the antigens of human and bovine mycobacteria in pulmonary tuberculosis patients].
Baginskiĭ SR; Kurmanbaev KK; Autenshlius AI; Agzamova RA
Probl Tuberk; 1985; (12):51-4. PubMed ID: 3938021
[No Abstract] [Full Text] [Related]
12. The isolation from romanian BCG substrain of non cross reacting antigens to Mycobacterium tuberculosis H37Rv strain.
Niculescu D; Stavri D; Stavri H; Claiciu I; Bărbulescu R
Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):213-9. PubMed ID: 6424629
[No Abstract] [Full Text] [Related]
13. Auto-antibodies in experimental chronic infective disease.
Ali AJ; Oakley CL
J Pathol Bacteriol; 1967 Apr; 93(2):413-33. PubMed ID: 4964137
[No Abstract] [Full Text] [Related]
14. [Serologic activity of purified phospholipids of Mycobacterium tuberculosis].
Sasaki A; Takahashi Y
C R Seances Soc Biol Fil; 1974; 168(4-5):626-9. PubMed ID: 4281705
[No Abstract] [Full Text] [Related]
15. Immunochemical study of Mycobacteria firmly bound lipids.
Hiu IJ; Amiel JL; Nikdjou K
Rev Eur Etud Clin Biol; 1970 Oct; 15(8):887-91. PubMed ID: 4993152
[No Abstract] [Full Text] [Related]
16. [Antibody synthesis in immunocompetent organs in BCG vaccination in experiment].
Averbakh MM; Litvinov VI
Arkh Patol; 1968; 30(7):33-8. PubMed ID: 4882266
[No Abstract] [Full Text] [Related]
17. Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae.
Kolk AH; Ho ML; Klatser PR; Eggelte TA; Kuijper S; de Jonge S; van Leeuwen J
Clin Exp Immunol; 1984 Dec; 58(3):511-21. PubMed ID: 6439449
[TBL] [Abstract][Full Text] [Related]
18. [Specificity of the mycobacteriostatic reaction].
Roger A; Roger F
C R Acad Hebd Seances Acad Sci D; 1969 Jun; 268(23):2842-4. PubMed ID: 4977595
[No Abstract] [Full Text] [Related]
19. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
Sugawara I; Udagawa T; Taniyama T
Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
[TBL] [Abstract][Full Text] [Related]
20. [Distribution of Mycobacterium tuberculosis antigens in tissues in experimental tuberculosis].
Gogebashvili NV; Averbakh MM; Romanova RIu
Probl Tuberk; 1969; 47(4):62-7. PubMed ID: 4983856
[No Abstract] [Full Text] [Related]
[Next] [New Search]
